{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:48:30Z","timestamp":1793771310612,"version":"4.6.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annemergmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.annemergmed.2023.09.003","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T19:57:53Z","timestamp":1702929473000},"page":"394-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["CALCIUM CHANNEL BLOCKERS SHOULD BE FIRST-LINE TREATMENT FOR HEMODYNAMICALLY STABLE SUPRAVENTRICULAR TACHYCARDIA"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6542-518X","authenticated-orcid":false,"given":"Megan A.","family":"Rech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2023.09.003_bib1","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jacc.2015.08.856","article-title":"2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society","volume":"67","author":"Page","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.annemergmed.2023.09.003_bib2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1197\/j.aem.2007.01.013","article-title":"U.S. emergency department visits for supraventricular tachycardia, 1993-2003","volume":"14","author":"Murman","year":"2007","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.09.003_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC Guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)","volume":"41","author":"Brugada","year":"2020","journal-title":"European Heart Journal"},{"key":"10.1016\/j.annemergmed.2023.09.003_bib4","first-page":"CD005154","article-title":"Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia","volume":"10","author":"Alabed","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annemergmed.2023.09.003_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.resuscitation.2009.01.017","article-title":"Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia","volume":"80","author":"Lim","year":"2009","journal-title":"Resuscitation"},{"key":"10.1016\/j.annemergmed.2023.09.003_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MEJ.0b013e3283400ba2","article-title":"The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis","volume":"18","author":"Delaney","year":"2011","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.09.003_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5811\/westjem.2013.9.16185","article-title":"Visual estimation of bedside echocardiographic ejection fraction by emergency physicians","volume":"15","author":"\u00dcnl\u00fcer","year":"2014","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.09.003_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MEJ.0000000000000866","article-title":"Assessing left ventricular systolic function by emergency physician using point of care echocardiography compared to expert: systematic review and meta-analysis","volume":"29","author":"Albaroudi","year":"2022","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.09.003_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0018578720925388","article-title":"The safety and efficacy of verapamil versus diltiazem continuous infusion for acute rate control of atrial fibrillation at an academic medical center","volume":"56","author":"Forshay","year":"2021","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.annemergmed.2023.09.003_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1553-2712.2009.00616.x","article-title":"Recent caffeine ingestion reduces adenosine efficacy in the treatment of paroxysmal supraventricular tachycardia","volume":"17","author":"Cabalag","year":"2010","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.09.003_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/clpt.1989.12","article-title":"Oral dipyridamole increases plasma adenosine levels in human beings","volume":"45","author":"German","year":"1989","journal-title":"Clin Pharmacol Ther"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019606442301212X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019606442301212X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:50:16Z","timestamp":1759294216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019606442301212X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S019606442301212X"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2023.09.003","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CALCIUM CHANNEL BLOCKERS SHOULD BE FIRST-LINE TREATMENT FOR HEMODYNAMICALLY STABLE SUPRAVENTRICULAR TACHYCARDIA","name":"articletitle","label":"Article Title"},{"value":"Annals of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annemergmed.2023.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Emergency Physicians.","name":"copyright","label":"Copyright"}]}}